Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in drugs

Indian Pharma Market Regains Growth

Indian pharmaceutical market regained its growth momentum in July after a weak trajectory in the previous three to four months

Read More

Indoco Remedies Q1 Net Marginally Down At Rs 19.8 Crore

Indoco Remedies on Friday reported a marginal decline in net profit at Rs 19.8 crore for the June quarter against Rs 20.8 crore in the corresponding period last fiscal

Read More

Torrent Pharma Q1 Net Slumps 55% To Rs 292 Crore

Drug firm Torrent Pharmaceuticals has reported 55 per cent fall in consolidated net profit at Rs 292 crore for the June quarter due to a dip in company’s US business

Read More

Dr Reddy's Labs Q1 Profit Slumps 75%, Misses Estimates

Dr Reddy's Laboratories Ltd, India's second-largest drugmaker, said its quarterly profit slumped 75 per cent, hurt by fierce competition in its largest market, the United States

Read More

Is Your Life A Vicious Circle?

Every prescription drug has a side effect: “It’s safe” and “everyone takes it” doesn’t mean it will not affect you. Read the label. Research online. There are lots of sites that list out side effects of the pills prescribed. Take an informed decision

Read More

Cipla To Set Up South Africa’s First Biopharma Facility

Drug firm Cipla will invest around Rand 1.3 billion (over Rs 590 crore) to launch a manufacturing facility in South Africa for the production of biosimilars

Read More

Govt Weighs Relaxing FDI Norms In Brownfield Pharma Companies

Government is considering a proposal to relax foreign direct investment norms in existing pharmaceutical companies with a view to attracting more overseas inflows

Read More

Analysts Cut Cipla 2017 Estimate After Weak Q4 Show

Cipla’s January-to-March quarter results were below the market expectation due to inventory write-offs or reductions, rationalisation of unviable geographies, higher research and development spends and regulatory costs

Read More

Glenmark Gets US Approval For Banzel Generic With 6-Month Exclusivity

The company said it is eligible for 180 days of shared generic drug marketing exclusivity for rufinamide tablets

Read More

India Eyes Oil-For-Drugs Deal With Venezuela To Recoup Pharma Cash

Indian officials say they have proposed an oil-for-drugs barter plan with cash-strapped Venezuela to recoup millions of dollars in payments owed to some of India's largest pharmaceutical companies

Read More

Playing Cat And Mouse

This situation is unique to India, where sales growth of companies is closely connected to brand launches

Read More

US FDA Warns Sri Krishna Pharma, Citing Drug-data Manipulation

Sri Krishna Pharmaceuticals, a supplier of paracetamol and other drugs to more than 60 countries, has been warned by the US Food and Drug Administration, which cited manipulation of its test results at a plant

Read More

Two Indian Generics Makers End Battle To Copy Drugs Amid Patent Debate

Two Indian drugmakers said they had given up a battle to copy drugs developed by Bristol Myers Squibb and AstraZeneca , blaming a lack of government support for cheap generics and pressure from Big Pharma

Read More

Pfizer, Allergan Scrap $160 Billion Deal After US Tax Rule Change

US drugmaker Pfizer Inc and Ireland-based Allergan Plc walked away from their $160 billion merger on Wednesday, a major win for President Barack Obama, who has been pushing to curb deals in which companies move overseas to save on taxes

Read More

Lupin Says It Sees No Supply Disruption At Plant Despite FDA Observations

The company said it did not expect any disruption to supply from its main manufacturing plant despite what it called minor observations made by the US Food and Drug Administration after an audit

Read More